Stable pharmaceutical composition for optimized delivery of...

Details Stable pharmaceutical composition for optimized delivery of... Stable pharmaceutical composition for optimized delivery of...

A - Human Necessities

61

K

A61K 31/496 (2006.01) A61K 31/00 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2735008

A pharmaceutical composition contains the compound 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1--yl)-1- [(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]- piperazine, and hydroxypropyl methyl cellulose (HPMC) having a viscosity of at least about 100 cP, wherein the composition does not contain any enzyme inhibitors.

L'invention porte sur une composition pharmaceutique qui contient le composé 1-benzoyl-4-[2-[4-méthoxy-7-(3-méthyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)méthyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoéthyl]-pipérazine, et de l'hydroxypropyl méthyl cellulose (HPMC) ayant une viscosité d'au moins environ 100 cP, la composition ne contenant pas d'inhibiteurs d'enzymes.

Affiliated with

Also associated with

Rating

Stable pharmaceutical composition for optimized delivery of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable pharmaceutical composition for optimized delivery of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable pharmaceutical composition for optimized delivery of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1438702